MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest Issue
We present selected private financings for May and June, including Alpheus Medical's over-subscribed $50 million Series B round to support its randomized controlled clinical trial on its novel sonodynamic therapy for glioblastoma. Plus a snapshot of our featured cancer impact investor, ACS BrightEdge.
Approxima aims to treat the root cause, not just the valvular symptoms, of tricuspid regurgitation, with a novel minimally invasive treatment.
To understand how changing guidelines and clinical practice have impacted TAVR’s utilization compared to SAVR across age groups over the last decade and what they portend for the future, Health Advances conducted a comprehensive analysis of real-world data of US aortic valve replacement procedures.